Dadi International Group Limited Overview
Dadi International Group is a micro-cap holding company listed on GEM. It is controlled by a Shanxi provincial state-owned environmental group and has shrunk from a HK$1.2bn-revenue book-distribution trader in FY2020 into a residual environmental-consultancy business. That business generated about HK$19.5m of revenue in FY2024 and about HK$6.0m in the first half of FY2025. The balance sheet is dominated by roughly HK$650m of aged, heavily impaired receivables, mostly from book distributors. On the other side sit about HK$588m of defaulted, 12%-coupon borrowings, mainly owed to its own substantial shareholder, Shanxi Environmental Group. The Group has negative equity of about HK$420m. In January 2023 two executive directors, including the Chairman, were taken in for disciplinary investigation by Shanxi provincial authorities. Since then the Company has run with a single executive director. It has proposed several pivots: healthcare supplements, an "ecological cultural park" cooperation, and mine restoration and stone processing. None has produced material revenue. The Exchange concluded that the Company lacks sufficient operations under GEM Rule 17.26 and issued a delisting decision in July 2026.
Company's own description
In its latest annual report (FY2024), the Company describes itself as an investment holding company. Its subsidiaries are principally engaged in providing environmental consultancy services, selling healthcare products, and publishing, purchasing and distributing books (AR2024; Interim Sep-2024 Note 1). The October 2025 resumption-progress announcement updated this description. It said the Company is principally engaged in environmental consulting services and book publishing and distribution, and is "gradually developing" mine development and restoration and stone processing and installation businesses (announcement 6 Oct 2025).
Reportable segments (as defined in the latest filings)
The Group reports five segments (Interim Sep-2024 Note 4):
-
Advertising and media-related services: design, production, agency and placement of advertisements, information consulting and marketing planning in Hong Kong and the PRC. Dormant, with no revenue in FY2023, FY2024 or H1 FY2025.
-
Financial leasing and other financial services: financial leasing and other financial services in the PRC. Leasing is suspended. Money lending and P2P activity have been permanently ceased.
-
Publication, purchase and distribution of books: in the PRC. Suspended for prudential capital-management reasons. HK$0.12m revenue in FY2023 and nil since.
-
Environmental consultancy services: in the PRC. This is the only revenue-generating segment.
-
Healthcare products: sales of imported dietary supplements in the PRC via e-commerce platforms. Revenue fell to HK$20k in FY2024 and nil in H1 FY2025.
Business and revenue model
Service revenue (recognised over time): Environmental consultancy is project-based. Inputs are direct labour plus outsourced technology services for on-site work (AR2024 cost-of-sales commentary). Revenue is recognised over time (Interim Sep-2024 Note 5).
Product revenue (point in time): books (historically the dominant revenue line) and healthcare products.
Financial services revenue (historical): interest income from corporate term loans (about 12 months, 7–9% rates, third-party guarantees) and P2P platform fees run by First FinTech (Shanghai). All of this has ceased (AR2024).
Mix: In FY2024, environmental consultancy was 99.9% of revenue (HK$19.513m of HK$19.533m) and healthcare products 0.1%. There is no subscription or licensing revenue.
Value-chain position, customers and end-markets
Environmental consultancy: The Group is a provider of advisory and technical services to PRC project owners on environmental protection, maintenance and restoration projects, linked to urbanisation, infrastructure and construction planning. The FY2022 ESG report says the Jinxin Keyuan acquisition broadened the business into radiation monitoring and mine remediation (ESG Report FY2022, as summarised by sustainabilityreports.com).
Customer concentration (FY2024): The largest customer was 7% of sales and the top five 24%. The largest supplier was 11% of purchases and the top five 40% (AR2024).
Books (historical): The Group was a mid-chain purchaser and distributor selling to downstream book distributors. These distributors are now the main source of the HK$600m+ receivable book, and the Group is suing them (AR2024; Interim Sep-2024 going-concern discussion).
Independent characterisation
Dadi is best understood as a distressed shell-like holding company with a small operating tail, not as an environmental-services platform. Three features dominate its economics.
Legacy receivables: gross trade receivables of HK$618m against an ECL allowance of HK$269m. More than 99% of net trade receivables are over 90 days old. There are also HK$293m of prepayments and HK$237m of other receivables (Interim Sep-2024 Note 12). Most of this relates to the suspended book business.
Related-party debt: HK$554m of borrowings from the substantial shareholder at 12% fixed, all classified as current and in default (Interim Sep-2024 Note 14; AR2024).
Revenue too small to service the debt: environmental-consulting revenue of HK$19.5m cannot cover finance costs of HK$66.9m, which include default interest (AR2024).
The Company's survival depends on parent-company support, offsetting debt against court-awarded receivables, or a restructuring. The Exchange judged in 2025–26 that none of these had been achieved.
Strategy
Stated strategy themes (AR2024; Interim Sep-2024)
Paraphrasing the filings, management's themes are:
-
recover accounts receivable through litigation;
-
greatly reduce operating costs;
-
keep a stable income base from environmental protection services;
-
"vigorously explore new business growth points" to materially improve operating conditions within the next fiscal year;
-
prioritise businesses with stable revenue given global political and economic instability.
Going-concern plan (AR2024 management position)
-
Reach a settlement with lender Shanxi Environmental Group Co., Ltd. This includes offsetting loan principal against court rulings in cases the lender brought, and agreeing waivers of interest and default interest.
-
Achieve profitable, cash-positive operations through cost controls.
-
Pursue judicial collection of receivables through PRC courts, public security bureaus and procuratorates.
-
Raise financing from investors, lenders and shareholders (shareholder loans, equity, bank loans).
-
Dispose of non-core businesses or financial assets.
Initiatives in the last 24 months
| Date | Initiative | Status / evidence |
|---|---|---|
| Sep 2024 | Cooperation protocol with Tianjin Heping Wenzhiyue Enterprise Service Trading Co. on an ecological cultural park and related industries | Described as "progressing normally" (Interim Sep-2024). No revenue disclosed. |
| FY2025 plan | Launch new healthcare products, including Japanese nattokinase supplements, aimed at younger PRC consumers | No sales reported in H1 FY2025 |
| FY2025 plan | Expand environmental consulting service offerings and customer base | Revenue continued to fall (−39.7% in H1) |
| 2,025 | Mine development and restoration; stone processing and installation | "Gradually commencing" (6 Oct 2025). GEM LRC judged these plans preliminary with no certainty of execution (Nov 2025 summary). |
| 2025–26 | Resumption plan under three Exchange guidance items: publish outstanding results and resolve audit modifications; demonstrate Rule 17.26 compliance; disclose all material information | Not met by the 1 Jul 2026 deadline; delisting decision 31 Jul 2026 |
ESG and cost programmes
ESG: paperless office and energy-saving measures. The FY2022 ESG report set a 6% GHG reduction target and a 10% waste reduction target.
Cost programme: cuts to administrative expenses (−15.5% in FY2024) and lease exits.
Medium-term targets and guidance
Not publicly disclosed. No quantitative guidance has been issued.
Products & Services
Legacy lending book (31 Mar 2024, AR2024): 19 corporate debtors, with gross balances from about RMB0.1m to RMB18m at 7–9% interest. The top five debtors make up about 81% of the gross amount. Accumulated ECL is about HK$109m, with full provision on P2P-model receivables. Judgments have been obtained against all P2P borrowers and/or guarantors, and enforcement, winding-up or bankruptcy proceedings are ongoing.
Product Portfolio
| Segment | Offering | Description / capabilities | Target customer | Launch / status | Pricing model |
|---|---|---|---|---|---|
Environmental consultancy | Environmental protection, maintenance and restoration consulting | Project consulting supported by in-house labour and outsourced technical services for on-site work | PRC project owners (urbanisation, infrastructure, construction planning) | Active; revenue declining (FY2024 HK$19.5m) | Project fees recognised over time; not publicly disclosed |
Environmental consultancy | Radiation monitoring and mine remediation (via Jinxin Keyuan, 60%) | Expanded scope following 2021 acquisition (FY2022 ESG report summary) | Mining and industrial operators (inferred) | Acquired 2021; profit guarantees missed in 2022 and 2023 | — |
New (2025) | Mine development and restoration | "Gradually commencing" per Oct 2025 announcement | — | Preliminary stage per GEM LRC (Nov 2025) | — |
New (2025) | Stone processing and installation | "Gradually commencing" per Oct 2025 announcement | — | Preliminary | — |
New (2024) | Ecological cultural park and related industries (Tianjin cooperation) | Cooperation protocol with Tianjin Heping Wenzhiyue Enterprise Service Trading Co.; "progressing normally" per Interim Sep-2024 | — | Announced 9 Sep 2024; no disclosed revenue | — |
Healthcare products | Imported dietary supplements | Supplements aimed at metabolism and internal circulation, sold via PRC e-commerce platforms | PRC consumers, increasingly younger buyers | Commenced ≈ FY2023; FY2024 sales HK$20k | Retail; not disclosed |
Healthcare products | Chewable functional natto snacks | Youth-oriented functional snack | Younger PRC consumers | Introduced ≈ FY2024 | — |
Healthcare products | Dietary-fibre functional series | Products featuring functional dietary-fibre ingredients | Younger PRC consumers | Introduced ≈ FY2024 | — |
Healthcare products | Nattokinase supplements from Japan (planned) | Planned new product line | PRC consumers | Announced as planned for FY2025 launch; launch not confirmed | — |
Books | Publication, purchase and distribution of books | Mid-chain purchase and distribution to downstream distributors | PRC book distributors | Suspended; FY2023 revenue HK$0.12m | Wholesale |
Financial services | Financial leasing | PRC finance leasing (Shenzhen Jia Ying Financial Leasing) | Corporate lessees | Suspended pending regulatory compliance (NFRA notice 27 Oct 2023) | Lease interest |
Financial services | Money-lending model | ~12-month corporate term loans, third-party guarantees, interest paid monthly | Corporates (working capital) | Permanently ceased | 7–9% interest (legacy portfolio) |
Financial services | P2P platform (First FinTech) | Receivable-transfer marketplace, custodial and collection services; 90–180-day loans | Individual and corporate users | Ceased 2018–2019; receivables acquired from users | Platform fees; not disclosed |
Advertising & media | Ad design, production, agency, placement; marketing planning | Media services in HK and PRC | Corporate advertisers | Dormant | — |
Film (legacy assets) | Deposits for film production and purchase of film rights | Deposits carried on the balance sheet (deposit for film production HK$31.4m in FY2022 unaudited results); subject to ECL | — | Legacy | — |
“—” = not publicly disclosed.
Financial Narrative
Income statement
Company-reported FY2024 detail (AR2024):
-
Revenue HK$19.5m (−46.5%); cost of sales HK$9.6m (−61.2%); gross profit HK$9.9m (−15.0%).
-
Administrative expenses HK$26.0m (−15.5%); net ECL allowance HK$9.3m (HK$7.1m trade/bills receivables, HK$2.2m other receivables/deposits).
-
Finance costs HK$66.9m (+35.5%, driven by default-interest provisions).
Loss for the year HK$91.2m: against HK$332.9m in FY2023.
Interim H1 FY2025 (six months to 30 Sep 2024, unaudited; HK$'000):
-
Revenue 6,002 (H1 FY2024: 9,954); cost of sales 2,737 (3,760); gross profit 3,265 (6,194).
-
Other gains nil (1,936); administrative expenses 9,856 (8,902); operating loss 6,591 (772).
-
Finance costs 9,528 (9,712); loss for the period 16,119 (10,954); attributable to owners 11,217 (7,623).
-
Reported basic LPS is 0.44 HK cents. Recomputing from the disclosed loss and share count gives about 0.31 HK cents, so the reported figure appears to be an arithmetic error.
-
Interim finance costs of HK$9.5m per half-year are far below the FY2024 annual HK$66.9m. This suggests default interest is booked at year-end or treated differently, and it limits comparability.
Margins and growth
Revenue CAGR, FY2020→FY2024 (4 years): about −64.5% a year (HK$1,230m to HK$19.5m).
Commentary. The trajectory has three phases.
-
FY2020 peak: a high-volume, low-margin book trading business (18% gross margin) that was profitable at the attributable level (about HK$34.6m).
-
FY2021–FY2022 collapse: book revenue fell sharply. Management attributes this to COVID-era cash-flow paralysis across the publishing chain, which nearly halted settlement and left distributors unable to pay. Large ECL charges on receivables, plus film and leasing deposits, drove operating losses of HK$124m and HK$325m (aggregator).
-
FY2023–FY2024 residual phase: revenue is now essentially environmental consulting. Gross margin rose (31.9% to 50.7%) mainly because revenue shrank faster than cost of sales. Operating losses narrowed as ECL charges fell and costs were cut. Net results are still driven by a 12% fixed-rate debt burden plus default interest.
Balance sheet
Sources: FY2023–FY2024 from AR2024 MD&A and Interim Sep-2024 comparatives. FY2020–FY2022 totals from TipRanks (FY-mapped, aggregator). Goodwill was nil at 31 Mar 2024 and 30 Sep 2024 (Interim Sep-2024), following the impairment assessment flagged in the 28 Jun 2024 announcement.
Latest balance sheet, 30 Sep 2024 (unaudited, HK$'000; Interim Sep-2024):
Non-current assets 30,326: PP&E 400; right-of-use 1,531; FVOCI financial assets 28,395.
Current assets 667,809: receivables, deposits and prepayments 653,613; FVTPL assets 727; cash 13,469.
Current liabilities 1,118,462: trade and other payables 492,201 (including dividends payable to NCI of 5,457); contract liabilities 481; borrowings 587,781 (secured 554,453; unsecured 33,328; 12% fixed); lease liabilities 203; tax payable 37,796.
Net current liabilities 450,653; net liabilities 420,327: - Capital deficiency attributable to owners 185,086; NCI −235,241.
- Accumulated losses 2,427,124 against share premium 1,828,573 and contributed surplus 311,538.
Receivables quality, 30 Sep 2024:
-
Trade receivables: gross 618,214 less ECL 268,865, net 349,349. Of the net figure, 346,647 (99.2%) is over 90 days old.
-
Other receivables 237,033, prepayments 292,980 and loans receivable 11,213, less ECL 237,665.
Cash flow
Half-year data (Interim Sep-2024, HK$'000):
-
Operating cash flow was +769 in H1 FY2025, against +4,050 in H1 FY2024.
-
Investing inflow was nil, against +1,685 in H1 FY2024 (dividend and interest receipts).
-
Debt repayments were nil, against 1,375 in H1 FY2024.
-
Capex was nil in both halves, with no PP&E additions.
The Company has paid no dividends since at least FY2020; final dividends were nil for FY2023 and FY2024 (AR2024). There were no buybacks or share-capital changes during FY2024 or H1 FY2025.
Ratios
Notes on methodology and gaps:
ROE: for FY2020 is approximated as attributable profit over year-end total equity. It is not meaningful from FY2022, when equity approached zero, and is negative thereafter.
ROA: uses the average of opening and closing total assets.
Gearing: for FY2023 and FY2024 is as reported in AR2024. Earlier years are computed from aggregator totals.
ROIC, debt/equity and net debt/EBITDA: are not meaningful because equity is negative and EBITDA is negative.
Interest coverage: is negative in FY2024 (EBIT −HK$23.6m against finance costs HK$66.9m).
Cash conversion cycle: is not computable meaningfully. Receivables at more than 30× revenue imply DSO above 10,000 days, which reflects legacy book receivables rather than the current business.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Status (latest) |
|---|---|---|
Advertising and media-related services | Ad design, production, agency, placement; information consulting; marketing planning (HK & PRC) | Dormant |
Financial leasing and other financial services | PRC financial leasing (Shenzhen Jia Ying Financial Leasing); money lending and P2P (First FinTech) | Leasing suspended; lending/P2P permanently ceased |
Publication, purchase and distribution of books | PRC book publishing, procurement, distribution | Suspended; receivable recovery litigation ongoing |
Environmental consultancy services | PRC environmental protection, maintenance and restoration consulting; radiation monitoring and mine remediation (via Jinxin Keyuan, per FY2022 ESG report) | Only active revenue segment |
Healthcare products | Imported dietary supplements, natto snacks, dietary-fibre products sold via PRC e-commerce | Near-zero sales; repositioning |
Books | 623,342 | 939,687 |
Advertising & media | 5,756 | 26,561 |
Financial services | 6,145 | 28,963 |
Environmental consultancy | 22,160 | 7,419 |
Healthcare | 4,699 | 10,186 |
Unallocated | 36,033 | 105,646 |
Total | 698,135 | 1,118,462 |
Revenue by Segment
| Segment (HKD K) | FY2023 | FY2024 | H1FY2024 | H1FY2025 |
|---|---|---|---|---|
Advertising and media-related services | 0 | 0 | 0 | 0 |
Financial leasing and other financial services | 0 | 0 | 0 | 0 |
Publication purchase and distribution of books | 120 | 0 | 0 | 0 |
Environmental consultancy services | 34,726 | 19,513 | 9,954 | 6,002 |
Healthcare products | 1,636 | 20 | 0 | 0 |
Total revenue | 36,482 | 19,533 | 9,954 | 6,002 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansSegment Revenue
| Segment | FY2024 YoY growth | FY2024 % of revenue | H1 FY2025 YoY growth |
|---|---|---|---|
Environmental consultancy services | −43.8% | 99.9% | −39.7% |
Healthcare products | −98.8% | 0.1% | n/a (nil both periods) |
Books | −100% | 0.0% | — |
Group | −46.5% | 100% | −39.7% |
Income Statement and Per-Share Data
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 1,230.00 | 615.94 | 37.96 | 36.48 | 19.53 |
Gross profit (HKD Mn) | 221.48 | 125.21 | 18.47 | 11.64 | 9.90 |
Operating income (HKD Mn) | 178.56 | -124.49 | -324.62 | -283.45 | -23.63 |
EBITDA (HKD Mn) | 186.57 | -116.39 | -320.91 | -281.46 | -22.48 |
Depreciation and amortisation (HKD Mn) | 8.02 | 7.94 | 3.84 | 1.99 | 1.15 |
Pre-tax income (HKD Mn) | 133.15 | -184.64 | -377.14 | -332.77 | -90.48 |
Net income attributable to owners (HKD Mn) | 34.59 | -152.50 | -217.84 | -287.15 | -58.44 |
Basic EPS (HKD) | 0.01 | -0.04 | -0.06 | -0.08 | -0.02 |
Diluted EPS (HKD) | 0.01 | -0.04 | -0.06 | -0.08 | -0.02 |
Dividend per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Weighted average shares (M) | 3,560 | 3,580 | 3,640 | 3,640 | 3,640 |
Margin Analysis (%)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Gross margin (%) | 18.0 | 20.3 | 48.7 | 31.9 | 50.7 |
Operating margin (%) | 14.5 | -20.2 | -855.2 | -777.0 | -121.0 |
EBITDA margin (%) | 15.2 | -18.9 | -845.4 | -771.5 | -115.1 |
Net margin attributable (%) | 2.8 | -24.8 | -573.9 | -787.1 | -299.2 |
Revenue growth YoY (%) | — | -49.9 | -93.8 | -3.9 | -46.5 |
Balance Sheet
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 638.46 | 1,340.00 | 1,080.00 | 713.28 | 689.43 |
Total liabilities (HKD Mn) | 148.15 | 970.43 | 1,060.00 | 1,049.60 | 1,096.24 |
Total equity incl. NCI (HKD Mn) | 490.31 | 370.49 | 26.08 | -336.97 | -406.81 |
Cash and bank balances (HKD Mn) | — | — | — | 8.88 | 12.99 |
Total borrowings (HKD Mn) | — | — | — | 605.40 | 584.63 |
Short-term borrowings (HKD Mn) | — | — | — | — | 584.63 |
Long-term borrowings (HKD Mn) | — | — | — | — | 0 |
Net debt (HKD Mn) | — | — | — | 596.52 | 571.65 |
Goodwill and intangibles (HKD Mn) | — | — | — | — | 0 |
Current assets (HKD Mn) | — | — | — | 691.40 | 659.31 |
Current liabilities (HKD Mn) | — | — | — | 1,049.60 | 1,096.24 |
Working capital (HKD Mn) | — | — | — | -358.20 | -436.93 |
Trade and other payables (HKD Mn) | — | — | — | 402.40 | 472.98 |
Receivables deposits and prepayments (HKD Mn) | — | — | — | 680.10 | 645.59 |
Financial Analysis
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Capex (HKD Mn) | — | — | — | — | 0 |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%) and Financial Ratios (x)
| Ratio | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
ROE attributable (%) | 7.1 | — | — | — | — |
ROA attributable (%) | — | -15.4 | -18.0 | -32.0 | -8.3 |
Current ratio (x) | — | — | — | 0.66 | 0.60 |
Gearing total liabilities to total assets (%) | 23.2 | 72.4 | 98.1 | 147.2 | 159.0 |
Borrowings to total assets (%) | — | — | — | 84.9 | 84.8 |
Asset turnover (x) | — | 0.62 | 0.03 | 0.04 | 0.03 |
Revenue by Region
| Region (HKD K) | FY2023 | FY2024 | H1FY2025 |
|---|---|---|---|
PRC revenue | 36,482 | 19,533 | 6,002 |
Hong Kong revenue | 0 | 0 | 0 |
Segment Overview (Annual)
| Segment | Geography | FY2024 revenue (HKD K) |
|---|---|---|
Environmental consultancy | PRC | 19,513 |
Healthcare products | PRC (imported products) | 20 |
Books | PRC | 0 |
Share Count (M)
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
Dividend per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Shares outstanding year-end (M) | 3,560 | 3,580 | 3,640 | 3,640 | 3,640 |
Valuation Snapshot
| Multiple | Value | Comment |
|---|---|---|
P/E | n/m | Loss-making |
EV/EBITDA | n/m | EBITDA negative; EV ≈ HK$36m + HK$571.7m net debt ≈ HK$608m |
EV/Sales | ≈ 31x | EV about HK$608m / FY2024 revenue HK$19.5m |
P/B | n/m | Negative book value |
Analyst Conclusions
Management guidance
No quantitative guidance. The qualitative outlook is to recover receivables, explore new growth points (mine restoration, stone processing, ecological parks, healthcare products) and prioritise stable-revenue businesses (AR2024; Interim Sep-2024; 6 Oct 2025 update). There is no consensus because there is no coverage.
Bull case
-
Parent-led balance-sheet repair. Shanxi Environmental Group is both the 28.24% controller and the holder of 94% of the debt. A court-sanctioned offset of loan principal against receivables, plus interest waivers, could eliminate most liabilities without any third-party capital (AR2024 going-concern plan).
-
Option value from legacy recoveries. About HK$506m of receivables has been provided for, and judgments have been obtained. Any enforcement recovery is pure upside to equity (AR2024; Interim Sep-2024 Note 12).
-
Clean operating core. The environmental consulting tail earns gross margins of 50–54%. Paired with an SOE parent's project pipeline in ecological restoration, it could be scaled into a compliant, if small, business (AR2024; Interim Sep-2024).
Bear case
-
Listing is effectively lost. The GEM Listing Committee has issued a cancellation decision, and two earlier reviews (GEM LC and GEM LRC, 2025) both went against the Company. A further review has historically low success odds when the underlying deficiencies (no audited FY2025 results, insufficient operations) persist (announcements Sep and Nov 2025; Aug 2026).
-
Equity is deeply negative. Net liabilities of HK$420m, with debt at 12% plus default interest, absorb any operating improvement. FY2024 finance costs (HK$66.9m) were 3.4 times revenue (AR2024).
-
Revenue is disappearing and the pivots are unproven. Revenue fell from HK$1.23bn (FY2020) to an annualised run-rate of about HK$12m (H1 FY2025 × 2). The Exchange found the new ventures preliminary, with no certainty of execution (GEM LRC, Nov 2025).
Catalysts and monitorables (next 12 months)
-
HKEXnews: any GEM Listing Review Committee decision on the delisting, or confirmation that the listing was cancelled on 17 Aug 2026.
-
Publication of FY2025 and FY2026 audited results, and whether the auditor's disclaimer is removed.
-
Any formal debt-settlement or offset agreement with Shanxi Environmental Group, or a parent privatisation or restructuring proposal.
-
Court outcomes and cash recoveries from book distributors and P2P debtors.
-
Exercise of the Jinxin Keyuan share-repurchase right (deadline 31 Dec 2024; status unconfirmed).
-
Revenue evidence from mine restoration, stone processing or the Tianjin ecological cultural park.
-
Post-delisting shareholder arrangements (registrar, unlisted share transfers, any exit offer).
Analyst verdict
Dadi International Group is no longer an investable listed equity in any conventional sense. The evidence is consistent across every filing reviewed.
-
Revenue shrank by about 98% between FY2020 and FY2024.
-
The balance sheet shows HK$420m of net liabilities, and borrowings of nearly HK$590m are in default.
-
The auditor disclaimed an opinion on the FY2024 accounts.
-
FY2025 results were never published.
-
The Exchange concluded through three separate decision layers that the Company lacks sufficient operations and assets to justify a listing, culminating in a cancellation decision on 31 July 2026.
The residual environmental consultancy business is real but immaterial. It generated HK$19.5m in FY2024 and about HK$6m in the half to September 2024, from roughly 72 employees. That is well below the scale needed to service even the cash interest on the shareholder loan.
The only credible path to value is a parent-orchestrated restructuring. The controlling shareholder is also the dominant creditor and is itself controlled by Shanxi's provincial state capital company. That gives it both the ability and the legal tools, through court-based offsets and interest waivers, to recapitalise the group. However, three years of announced plans have produced no executed settlement. The 2023 discipline investigation of the former chairman also suggests the parent's priorities may lie in containment rather than revival.
For minority shareholders, the realistic outcomes are delisting with an illiquid unlisted holding, or a highly dilutive restructuring. Recovery value per share is speculative and cannot be estimated responsibly from public data.
Rating view: Avoid / not rateable. The security should be classified as distressed, suspended, and probably delisted pending confirmation. Any engagement should be limited to monitoring HKEXnews for (i) the final listing-status outcome and (ii) any formal debt settlement with Shanxi Environmental Group, which is the single variable that could change this assessment.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age (AR2024) | Background and education | Source |
|---|---|---|---|---|---|
Wu Xiaoming (吳筱明) | Executive Director; Interim Chairman; Executive Vice Chairman; CEO; Compliance Officer; Nomination Committee chair; Remuneration Committee member | CEO 28 Apr 2016; ED 30 Sep 2016; EVC 3 Apr 2018; Interim Chairman 28 Jun 2023 |
| Master's in economics and management, Party School of the Shaanxi Provincial Committee of the CPC. Senior economist and engineer. Experience in financing, large-project investment and corporate strategy. Director of Dadi International Culture Media Holdings, Dadi Great Wall Financial Holdings and Dadi International Environmental Investment. | AR2024; Yahoo |
Ju Mengjun (俱孟軍) | Non-executive Director | 22 Dec 2020 | 68 | More than 30 years at Xinhua News Agency, including deputy chief editor and president of the Asia-Pacific and Hong Kong branches. ED and co-chairman of Xinhua News Media Holdings (0309.HK) 2011–2018. Peking University (Russian Language and Literature); Pushkin State Russian Language Institute. | AR2024 |
Zhang Xiongfeng (張雄峰) | Non-executive Director; Audit Committee member; holds 6.52% | 3 Apr 2018 | 56 | Investment banking and corporate finance. Former NED of Fire Rock Holdings (1909.HK) and Pa Shun International (574.HK). Former ED and chairman of Hang Tai Yue Group (8081.HK). | AR2024; Interim Sep-2024 |
Dr Zhang Wei (張煒) | INED; Remuneration Committee chair; Audit and Nomination Committee member | Nov 2017 | 70 | Taught development economics and the Chinese economy at the University of Cambridge from 2000. Founding director of the Economic Research Centre for Greater China (Cambridge). Executive director and CEO of Mingly Corporation. Former NED of Hanison Construction (896.HK). | AR2024 |
Law Yui Lun (羅裔麟) | INED; Audit Committee chair | 1 Nov 2017 | 62 | FCCA, with more than 30 years in audit, tax, insolvency and advisory. Former INED of Shougang Concord Century (0103.HK), CBK Holdings (8428.HK) and China Trustful (8265.HK). | AR2024 |
Dr Jin Lizuo (金立佐) | INED; Audit, Remuneration and Nomination Committee member | 11 Feb 2020 | 66 | Supervisor of CICC (3908.HK) since 2015 and a member of its founding preparatory group. INED of Beijing Enterprises Environment Group (0154.HK). BA in economics, Peking University; DPhil in economics, Oxford. | AR2024 |
Zou Yu (鄒宇) | INED (female) | ≈ 20 Dec 2024 | — | Not publicly disclosed in reviewed sources | MarketScreener; board lists 2025–26 |
“—” = not publicly disclosed.
Governance Overview
| Attribute | Status |
|---|---|
Board size | 7 (1 ED, 2 NEDs, 4 INEDs) since Dec 2024; 6 at 31 Mar 2024 |
Independence | 4 of 7 INEDs (57%), above the GEM one-third minimum |
Chair/CEO separation | Not separated. Wu Xiaoming has been both Interim Chairman and CEO since 28 Jun 2023, a deviation from CG Code C.2.1. |
Committees | Audit (chair Law Yui Lun); Remuneration (chair Dr Zhang Wei); Nomination (chair Wu Xiaoming) |
Meetings FY2024 | 4 board meetings, 3 audit, 1 remuneration, 2 nomination; full attendance by sitting directors |
Gender diversity | All-male board until Zou Yu's appointment in Dec 2024. Workforce 30 female / 43 male (31 Mar 2024). |
Dealing breach | 400,000 shares held by Wu Xiaoming were sold by a margin lender during the results blackout period (29 Apr–3 May 2024). The board treated this as exceptional circumstances under GEM Rule 5.67. |
Reporting compliance | Breached GEM Rule 18.49(1) through late FY2024 results. FY2025 results never published. |
Major Shareholders
| Holder | Shares | % of issued |
|---|---|---|
Dadi International Holdings Co., Ltd, ultimately owned by Shanxi Provincial State-owned Capital Investment and Operation Co., Ltd → Shanxi Dadi Environmental Investment Holdings (100%) → Shanxi Environmental Group (90%) → Dadi International Holdings (100%) | 1,027,985,995 | 28.24% |
Zhang Xiongfeng (NED) | 237,209,900 | 6.52% |
Wu Xiaoming (ED/CEO) | 31,880,000 | 0.88% |
Other public shareholders | ~2,343.6m (derived) | ~64.4% |
Competitive Landscape
Competitors by Segment
| Segment | Named competitors (illustrative peer set) | Dadi's relative position |
|---|---|---|
Environmental consultancy, testing and monitoring (PRC) | Centre Testing International (300012.SZ); Pony Testing (300887.SZ); Beijing Enterprises Environment Group (0154.HK); China Everbright Environment (0257.HK); many local Shanxi and provincial design institutes and consulting firms | Micro-scale (FY2024 revenue HK$19.5m); no disclosed differentiation |
Mine restoration (new) | Provincial state-owned environmental groups, including the Company's own parent ecosystem (Shanxi Environmental Group) | Pre-revenue |
Imported healthcare supplements (PRC e-commerce) | By-Health (300146.SZ); Swisse/H&H Group (1112.HK); Blackmores; numerous cross-border e-commerce sellers | Negligible (HK$20k FY2024) |
Book distribution (PRC) | Xinhua Wenxuan (0811.HK); China South Publishing & Media (601098.SH); private distributors | Suspended |
Financial leasing (PRC) | Thousands of licensed leasing companies | Suspended |
Competitor Detail
| Metric | Dadi (FY2024) |
|---|---|
Revenue | HK$19.5m |
Revenue growth | −46.5% |
Gross margin | 50.7% |
Net margin (attrib.) | about −299% (aggregator) |
Recent Developments
--



